Osimertinib Resistance With a Novel EGFR L858R/A859S/Y891D Triple Mutation in a Patient With Non-Small Cell Lung Cancer: A Case Report

Targeted drug therapy based on the types of epidermal growth factor receptor (EGFR) gene mutations has been widely used in the diagnosis and treatment of patients with non-small cell lung cancer (NSCLC). With the development of next-generation sequencing (NGS) technology, more and more EGFR-tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanli, Zhang, Xing, Wang, Ruixiao, Qin, Jiayue, Wang, Juan, Li, Zhimin, Song, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727459/
https://www.ncbi.nlm.nih.gov/pubmed/33324543
http://dx.doi.org/10.3389/fonc.2020.542277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727459/
https://www.ncbi.nlm.nih.gov/pubmed/33324543
http://dx.doi.org/10.3389/fonc.2020.542277

Ejemplares similares